Hexahydrochromeno[4,3-b]pyrrole derivatives as acetylcholinesterase inhibitors

Journal of Medicinal Chemistry

Volumn 44, Issue 1, 2001, Pages 105-109

  Bolognesi, M L ^a   Andrisano, V ^a   Bartolini, M ^a   Minarini, A ^a   Rosini, M ^a   Tumiatti, V ^a   Melchiorre, C ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 1,2,3,3A,4,9B HEXAHYDROCHROMENO[4,3 B]PYRROL 6 YL N METHYLCARBAMATE; 1 METHYL 1,2,3,3A,4,9B HEXAHYDROCHROMENO[4,3 B]PYRROL 7 YL N METHYLCARBAMATE OXALATE; 1 METHYL 1,2,3,3A,4,9B HEXAHYDROCHROMENO[4,3 B]PYRROL 8 YL N METHYLCARBAMATE OXALATE; CAPROCTAMINE; CARBAMIC ACID DERIVATIVE; CHOLINERGIC RECEPTOR; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; CHROMENE DERIVATIVE; DIAMIDE; DIAMINE; HEXAHYDROCHROMENO[4,3 B]PYRROLE DERIVATIVE; HEXAHYDROPYRROLOL[2,3 B]INDOLE; PHYSOSTIGMINE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DESIGN; DRUG POTENCY; DRUG SYNTHESIS; ENANTIOMER; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; NONHUMAN; TIME;

BENZOPYRANS; CHOLINESTERASE INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; PHYSOSTIGMINE; PYRROLES; PYRROLIDINES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0035804333     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm000991r     Document Type: Article

References (21)

1. Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease
2. Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme
3. Design, synthesis and biological evaluation of symmetrically and unsymmetrically substituted methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists
4. Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease
5. Phenserine and ring C hetero-analogues: Drug candidates for treatment of Alzheimer's disease
6. 8-bisnorphysostigmine. Their antipodal isomers, and other potential metabolites of phenserine
7. 4
8. Comparison of (-)-eseroline with (+)-eseroline and dihydroseco analogues in antinociceptive assays: Confirmation of rubreserine structure by x-ray analysis
9. Practical synthesis of innatural (+)-physostigmine and carbamate analogues
10. Bioactive alkaloids. 4. Results of recent investigations with colchicine physostigmine
11. Syntheses, resolution, and structure - Activity relationships of potent acetylcholinesterase inhibitors: 8-carbaphysostigmine analogues
12. Phenylcarbamates of (-)-eseroline, (-)-N1-Noreseroline and (-)-physovenol: Selective inhibitors of acetyl and/or butyrylcholinesterase
13. Thiaphysoverine and carbamate analogues: A new class of potent inhibitors of cholinesterases
14. Total syntheses and anticholiesterase activities of (3aS)-N(8)-norphysostigmine, (3aS)-N(8)-norphenserine, their antipodal isomers, and other N(8)-substituted analogues
15. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease
16. Carbamylation and binding constants for the inhibition of acetylcholinesterase by physostigmine
17. Mechanism-based inhibitors of mammalian cholesterol esterase
18. The aromatic patch of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors
19. Aromatic hydroxylation of β-adrenergic antagonists. Formation of 4′- and 5′-hydroxy-1-(isopropylamino)-3-[2′-(allyloxy)phenoxy]-2-propanol from oxprenolol
20. A new and rapid colorimetric determination of acetylcholinesterase activity